NeuroPace (NPCE) Total Debt (2020 - 2026)
NeuroPace's (NPCE) quarterly Total Debt came in at $59.0 million in Q1 2026, down 1.28% year-on-year from $59.8 million in Q1 2025, and little changed quarter-over-quarter from $58.9 million in Q4 2025.
NeuroPace (NPCE) Total Debt (2020 - 2026) Analysis & Trends
NeuroPace's Total Debt history runs 7 years deep, the most recent figure standing at $59.0 million for Q1 2026.
- On a quarterly basis, Total Debt fell 1.28% year-over-year to $59.0 million in Q1 2026; TTM through Mar 2026 was $59.0 million, a 1.28% decrease from a year earlier, with the FY2025 full-year figure at $58.9 million, down 1.08% from the prior year.
- Total Debt was little changed at $59.0 million in Q1 2026 per NPCE's latest filing, from $58.9 million in the prior quarter.
- Across five years, Total Debt topped out at $59.8 million in Q1 2025 and bottomed at $50.1 million in Q1 2022.
- The 5-year median for Total Debt is $58.0 million (2024), against an average of $56.4 million.
- Across the five-year window, Total Debt retreated 5.71% in 2022 and advanced 7.76% in 2024, its largest moves.
- Year by year, Total Debt stood at $52.9 million in 2022, then grew by 7.64% to $57.0 million in 2023, then grew by 4.51% to $59.5 million in 2024, then dropped by 1.08% to $58.9 million in 2025, then climbed by 0.23% to $59.0 million in 2026.
- Per Business Quant, the three latest NPCE Total Debt figures stand at $59.0 million (Q1 2026), $58.9 million (Q4 2025), and $58.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 34.05 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 14.72 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 27.96 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 11.03 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 598.50 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 9.48 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.14 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 3.18 Bn |
| 10 | NeuroPace | 494.96 Mn | 440.98 Mn | 18.05 Mn | 59.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 59.02 Mn |
| Dec 31, 2025 | 58.88 Mn |
| Sep 30, 2025 | 58.75 Mn |
| Jun 30, 2025 | 58.62 Mn |
| Mar 31, 2025 | 59.79 Mn |
| Dec 31, 2024 | 59.53 Mn |
| Sep 30, 2024 | 59.27 Mn |
| Jun 30, 2024 | 59.02 Mn |
| Mar 31, 2024 | 58.04 Mn |
| Dec 31, 2023 | 56.95 Mn |
| Sep 30, 2023 | 55.89 Mn |
| Jun 30, 2023 | 54.85 Mn |
| Mar 31, 2023 | 53.86 Mn |
| Dec 31, 2022 | 52.91 Mn |
| Sep 30, 2022 | 51.95 Mn |
| Jun 30, 2022 | 51.02 Mn |
| Mar 31, 2022 | 50.12 Mn |
| Dec 31, 2021 | 49.85 Mn |
| Sep 30, 2021 | 49.58 Mn |
| Jun 30, 2021 | 49.35 Mn |